Previous studies of inhibitors of ricin A chain (RA) mainly focused on the analogues of adenine and ribosomal RNA (rRNA) substrates. In this paper, a novel antagonist peptide (named PT) was designed rationally based on the crystal structure of the complex RA–rRNA. Theoretical results had clearly revealed the blockage of PT in the RA–rRNA interaction. The competitive inhibition experiment indicated that PT could significantly inhibit the binding activity of RA with anti-RA antibody. In order to further prove the competitive effect of PT against RA, N-glycosidase antagonizing activity of PT in cell-free system was evaluated using luciferase protein synthesis inhibition assay. Consequent data demonstrated that, at a RA level (0.022 nM) giving 50% decrease of protein synthesis in the absence of the peptide, protein synthesis could be recovered by the peptide for up to 80% at a level of 0.1 microgram/ml. This study highlights the interest of computation-aided method in the design of novel peptides with the ability to block the deleterious biological effects of RA. In addition, the method of luciferase protein synthesis inhibition assay in cell-free system which should provide rapid, sensitive, selective, and quantitative assessment may be developed to evaluate the potential antagonizing activity of RA inhibitors.
Similar content being viewed by others
References
T. K. Amukele V. L. Schramm (2004) Biochemistry 43 4913–4922 Occurrence Handle10.1021/bi0498508 Occurrence Handle15109249
R. Baluna J. Rizo B. E. Gordon V. Ghetie E. S. Vitetta (1999) Proc. Natl. Acad. Sci. USA 96 3957–3962 Occurrence Handle10.1073/pnas.96.7.3957 Occurrence Handle10097145
N. Ban P. Nissen J. Hansen M. Capel P. B. Moore T. A. Steitz (1999) Nature 400 841–847 Occurrence Handle10.1038/23641 Occurrence Handle10476961
X. Y. Chen P. J. Berti V. L. Schramm (2000) J. Am. Chem. Soc 122 1609–1617 Occurrence Handle10.1021/ja992750i
X. Y. Chen T. Link V. L. Schramm (1996) J. Am. Chem. Soc 118 3067–3068 Occurrence Handle10.1021/ja9600385
Y. Endo R. Morishita K. M. Imashevich S. Yodhinari (1998) J. Toxicol. Toxin Rev 17 427–439
J. R. Hesselberth D. Miller J. Robertus A. D. Ellington (2000) J. Biol. Chem 275 4937–4942 Occurrence Handle10.1074/jbc.275.7.4937 Occurrence Handle10671531
H. B. Hines E. E. Brueggemann M. L. Hale (2004) Anal. Biochem 330 119–122 Occurrence Handle10.1016/j.ab.2004.03.046 Occurrence Handle15183769
A. S. Khan R. Thompson C. Cheng J. I. Valdes (2003) Biotech. Lett 25 1671–1675 Occurrence Handle10.1023/A:1025618032335
R. J. Kreitman (1999) Curr. Opin. Immunol 11 570–578 Occurrence Handle10.1016/S0952-7915(99)00005-9 Occurrence Handle10508704
R. S. Liu J. H. Yang W. Y. Liu (2002) Eur. J. Biochem 269 4746–4752 Occurrence Handle10.1046/j.1432-1033.2002.03165.x Occurrence Handle12354105
J. M. Lord N. A. Jolliffe C. J. Marsden et al. (2003) Toxicol. Rev 22 53–64 Occurrence Handle14579547
J. M. Lord L. M. Roberts J. D. Robertus (1994) FASEB J 8 201–208 Occurrence Handle8119491
C. J. Marsden V. Fulop P. J. Day J. M. Lord (2004) Eur. J. Biochem 271 153–162 Occurrence Handle10.1046/j.1432-1033.2003.03914.x Occurrence Handle14686928
A. F. Monzingo J. D. Robertus (1992) J. Mol. Biol 227 1136–1145 Occurrence Handle10.1016/0022-2836(92)90526-P Occurrence Handle1433290
K. N. Morris I. G. Wool (1994) Proc. Natl. Acad. Sci. USA 91 7530–7533 Occurrence Handle8052614
J. E. O’Toole D Esseltine T. J. Lynch J. M. Lambert M. L. Grossbard (1998) Curr. Top. Microbiol. Immunol 234 35–56 Occurrence Handle9670611
W. H. Pei J. N. Feng H. X. Lei Y. Li B. F. Shen (1999) Prog. Biochem. Biophys 26 270–272
S. Roday T. Amukele G. B. Evans P. C. Tyler R. H. Furneaux V. L. Schramm (2004) Biochem 43 4923–4933 Occurrence Handle10.1021/bi0498499
L. Y. Tam C. Landolt-Marticorena R. A. F. Reithmeier (1996) Biochem. J 318 645–648 Occurrence Handle8809058
S. A. Weston A. D. Tucker D. R. Thatcher D. J. Derbyshire R. A. Pauptit (1994) J. Mol. Biol 244 410–422 Occurrence Handle10.1006/jmbi.1994.1739 Occurrence Handle7990130
X. J. Yan T. Hollis M. Svinth et al. (1997) J. Mol. Biol 266 1043–1049 Occurrence Handle10.1006/jmbi.1996.0865 Occurrence Handle9086280
Author information
Authors and Affiliations
Corresponding author
Additional information
Shuntao Wang and Jiannan Feng Contributed Equally to This Work
Rights and permissions
About this article
Cite this article
Wang, S., Feng, J., Guo, J. et al. Structural-Based Rational Design of an Antagonist Peptide That Inhibits the Ribosome-Inactivating Activity of Ricin A Chain. Int J Pept Res Ther 11, 211–218 (2005). https://doi.org/10.1007/s10989-005-6792-2
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10989-005-6792-2